C16orf74 is associated with adverse clinical characteristics of HNSC.
<p>Association of C16orf74 expression with age (a), gender (b), primary therapy outcome (c), tumor status (d), clinical T stage (e), clinical N stage (f), clinical M stage (g), clinical stage (h), pathologic T stage (i), pathologic N stage (j), pathologic M stage (k), and pathologic stage (l)...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>Association of C16orf74 expression with age (a), gender (b), primary therapy outcome (c), tumor status (d), clinical T stage (e), clinical N stage (f), clinical M stage (g), clinical stage (h), pathologic T stage (i), pathologic N stage (j), pathologic M stage (k), and pathologic stage (l) based on TCGA database analysis. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns: not significant.</p> |
|---|